Malaria, potato famine pathogen share surprising traitMay 30, 2006COLUMBUS , Ohio — Two wildly different pathogens — one that infects vegetables, the other infecting humans—essentially use the same protein code to get their disease-causing proteins into the cells of their respective hosts. That's what researchers from Ohio State and Northwestern universities report in a study published in the current issue of the journal PLoS Pathogens. The scientists were surprised to learn that the pathogen that causes malaria in humans and the microbe that caused the Irish potato famine use identical protein signals to start an infection. "I don't think anyone expected this," said Sophien Kamoun, a study co-author and an associate professor of plant pathology at Ohio State's Ohio Agricultural Research and Development Center in Wooster. "These are very different pathogens, and we never realized that there might be some similarities between them." Kamoun says not to worry — there's no chance that the potato pathogen will jump to humans, nor is it likely that the malaria parasite will start infecting plants. However, he said it's feasible to think that one day researchers could develop a drug with a dual purpose — one that would stop both Plasmodium falciparum, which causes malaria, and Phytophthora infestans, the microbe that triggers late potato blight in vegetables including potatoes, soybeans and tomatoes. "It sounds crazy, but it's not totally ridiculous to consider such a drug," said Kamoun, who is an expert on the Phytophthora group of pathogens. He conducted the study with lead author Kasturi Haldar, of Northwestern, and with colleagues from both Ohio State and Northwestern. Each year, malaria kills more than one million people — mostly young African children — and Phytophthora pathogens devastate a wide range of food and commercial crops. The researchers swapped a small sequence of proteins, called the leader sequence, in P. falciparum with the leader sequence of P. infestans. A leader sequence is a group of about 20 to 30 amino acids on a protein secreted by the parasite. This sequence contains instructions on how to enter, and therefore start infecting, a plant or animal cell. In laboratory experiments, the researchers infected human red blood cells with the modified malarial pathogen. Results showed that malaria proteins could just as effectively enter and infect a cell when it contained the P. infestans leader sequence instead of its own. "Our findings show that very distinct microbes can share similar strategies for delivering toxic proteins to their targets," Kamoun said. About a year and a half ago, Kamoun and his group at Ohio State read studies conducted by the Northwestern researchers that described the leader sequence of the malaria parasite. The similarity between this and the leader sequence of P. infestans was remarkable, he said. "So we decided to collaborate and see if the sequences were not just similar, but also functionally the same," he said. "It turned out that they were. But although the mechanism of getting virulence proteins into a host cell is very similar, the infection-causing proteins that are delivered to a host are completely different." To Kamoun's knowledge, this is the first paper to show that such dissimilar pathogens of this type—both are eukaryotic organisms — share a remarkably similar trait. He and his colleagues aren't sure how to explain this phenomenon, as these pathogens belong to distinctly different evolutionary groups. This work was supported by grants from the National Institutes of Health and by a National Science Foundation's Plant Genome grant. Ohio State |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||